Creatine kinase Health Dictionary

Creatine Kinase: From 2 Different Sources


An ENZYME which is proving to be of value in the investigation and diagnosis of muscular dystrophy (see MUSCLES, DISORDERS OF – Myopathy), in which it is found in the blood in greatly increased amounts.
Health Source: Medical Dictionary
Author: Health Dictionary
an enzyme involved in the metabolic breakdown of creatine to creatinine. Isomers of creatine kinase originate from brain and thyroid (BB), skeletal muscle (MM), and cardiac muscle (MB). Any damage to these tissues causes an increase of the isomer in the serum, which can be used in diagnosis, particularly of myocardial infarction.
Health Source: Oxford | Concise Colour Medical Dictionary
Author: Jonathan Law, Elizabeth Martin

Creatine

A nitrogenous substance, methyl-guanidineacetic acid. The adult human body contains about 120 grams – 98 per cent of which is in the muscles. Much of the creatine in muscles is combined with phosphoric acid as phosphocreatine, which plays an important part in the chemistry of muscular contraction.... creatine

Kinase

n. 1. an agent that can convert the inactive form of an enzyme (see proenzyme) to the active form. 2. an enzyme that catalyses the transfer of phosphate groups. An example is *phosphofructokinase.... kinase

Protein Kinase

an enzyme that catalyses the transfer of a phosphate group from ATP to a specific amino acid residue of an intracellular protein (usually serine, threonine, or tyrosine), thereby affecting the biological activity of the protein. Protein kinase inhibitors are drugs that block the action of protein kinases in tumour cells and are used in the treatment of cancer. They include *sorafenib, *sunitinib, and *temsirolimus. See also tyrosine kinase inhibitor.... protein kinase

Tyrosine Kinase Inhibitor

any one of a class of drugs that interfere with cell growth in a variety of different ways by inhibiting the action of tyrosine kinases. This family of enzymes, which occur both within cells and as components of cell-membrane receptor sites, have an important role in cell division and cell growth. Many tumour cells have been shown to have both intracellular enzymes and extracellular receptor sites, and a variety of anticancer agents have been developed to inhibit enzyme activity at these sites. Among these drugs are *imatinib, dasatinib, and nilotinib, used for treating chronic myeloid leukaemia; *sunitinib, for treating renal cell carcinoma; and erlotinib, for treating pancreatic cancer and non-small-cell lung cancer. See also epidermal growth factor receptor.... tyrosine kinase inhibitor



Recent Searches